Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

Case Reports in Anesthesiology
Volume 2013, Article ID 953859, 4 pages
http://dx.doi.org/10.1155/2013/953859
Case Report

A Minimal-Invasive Metabolic Test Detects Malignant Hyperthermia Susceptibility in a Patient after Sevoflurane-Induced Metabolic Crisis

Department of Anesthesia and Critical Care, University of Wuerzburg, Oberduerrbacher Street 6, 97080 Wuerzburg, Germany

Received 17 July 2013; Accepted 27 August 2013

Academic Editors: A. Han, H. Shankar, and C.-S. Sung

Copyright © 2013 Frank Schuster et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Schuster and C. R. Müller-Reible, “Malignant hyperthermia diagnostics, treatment and anaesthetic management,” Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie, vol. 44, no. 11-12, pp. 758–763, 2009 (German). View at Publisher · View at Google Scholar · View at Scopus
  2. T. Girard, S. Treves, E. Voronkov, M. Siegemund, and A. Urwyler, “Molecular genetic testing for malignant hyperthermia susceptibility,” Anesthesiology, vol. 100, no. 5, pp. 1076–1080, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. F. R. Ellis, P. J. Halsall, and H. Ording, “A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European malignant hyperpyrexia group,” British Journal of Anaesthesia, vol. 56, no. 11, pp. 1267–1269, 1984. View at Google Scholar · View at Scopus
  4. F. Schuster, T. Metterlein, S. Negele et al., “An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study,” Anesthesia and Analgesia, vol. 107, no. 3, pp. 909–914, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Bandschapp and T. Girard, “Malignant hyperthermia,” Swiss Medical Weekly, vol. 142, no. 7, Article ID w13652, 2012. View at Google Scholar
  6. P. M. Hopkins, “Malignant hyperthermia: pharmacology of triggering,” British Journal of Anaesthesia, vol. 107, no. 1, pp. 48–56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. S. Lee, W. Y. Kim, S. H. Lee et al., “A case of malignant hyperthermia during anesthesia induction with sevoflurane,” Korean Journal of Anesthesiology, vol. 59, pp. S6–S8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Adam, U. Gottschaldt, N. C. Pausch, H. Rüffert, and K. M. Sipli, “Fulminant MH crisis during the ninth general anaesthesia,” Anästhesiologie, Intensivmedizin, Notfallmedizin und Schmerztherapie, vol. 42, no. 10, pp. 692–699, 2007 (German). View at Publisher · View at Google Scholar · View at Scopus
  9. K. P. E. Glahn, F. R. Ellis, P. J. Halsall et al., “Recognizing and managing a malignant hyperthermia crisis. Guidelines from the European Malignant Hyperthermia Group,” British Journal of Anaesthesia, vol. 105, no. 4, pp. 417–420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Krause, M. U. Gerbershagen, M. Fiege, R. Weißhorn, and F. Wappler, “Dantrolene—a review of its pharmacology, therapeutic use and new developments,” Anaesthesia, vol. 59, no. 4, pp. 364–373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Schuster, H. Schöll, M. Hager, R. Müller, N. Roewer, and M. Anetseder, “The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs,” Anesthesia and Analgesia, vol. 102, no. 2, pp. 468–472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Schuster, P. Tas, R. Müller, N. Roewer, and M. Anetseder, “Pharmacologic modulation of skeletal muscle metabolism: a microdialysis study,” Basic and Clinical Pharmacology and Toxicology, vol. 98, no. 4, pp. 372–376, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Urwyler, T. Deufel, T. McCarthy, and S. West, “Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia,” British Journal of Anaesthesia, vol. 86, no. 2, pp. 283–287, 2001. View at Publisher · View at Google Scholar · View at Scopus